| Previous close | 0.0500 |
| Open | 0.0600 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 1.00 |
| Expiry date | 2025-01-17 |
| Day's range | 0.0500 - 0.0600 |
| Contract range | N/A |
| Volume | |
| Open interest | 7.81k |
Business WireSenseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association’s 84th Scientific Sessions
GERMANTOWN, Md., June 13, 2024--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to host a business update and analyst event during the American Diabetes Association’s 84th Scientific Sessions in Orlando, FL.
Business WireSenseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference
GERMANTOWN, Md., May 29, 2024--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Sidoti Small Cap Conference, being held in virtually.
ZacksSenseonics' (SENS) Deal With Mercy to Drive Eversense CGM Sales
Senseonics Holdings (SENS) collaborates with Mercy to bring its Eversense CGM to a healthcare system that is likely to drive its adoption.
